S&P 500   3,952.19 (+0.46%)
DOW   33,667.62 (+0.21%)
QQQ   282.85 (+0.83%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
S&P 500   3,952.19 (+0.46%)
DOW   33,667.62 (+0.21%)
QQQ   282.85 (+0.83%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
S&P 500   3,952.19 (+0.46%)
DOW   33,667.62 (+0.21%)
QQQ   282.85 (+0.83%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
S&P 500   3,952.19 (+0.46%)
DOW   33,667.62 (+0.21%)
QQQ   282.85 (+0.83%)
AAPL   141.86 (+0.65%)
MSFT   246.50 (+0.87%)
META   115.33 (+1.23%)
GOOGL   94.01 (-0.98%)
AMZN   89.63 (+1.32%)
TSLA   171.75 (-1.32%)
NVDA   168.40 (+4.47%)
NIO   13.37 (+6.28%)
BABA   94.11 (+6.54%)
AMD   69.57 (-0.81%)
T   19.15 (-0.78%)
MU   55.14 (+2.45%)
CGC   3.02 (-6.79%)
F   13.09 (-0.08%)
GE   83.26 (-2.05%)
DIS   92.46 (+0.34%)
AMC   6.11 (+0.99%)
PYPL   74.22 (-0.27%)
PFE   51.73 (+2.97%)
NFLX   308.08 (-0.11%)
NASDAQ:EYE

National Vision - EYE Stock Forecast, Price & News

$39.13
-0.98 (-2.44%)
(As of 12/8/2022 02:10 PM ET)
Add
Compare
Today's Range
$39.05
$40.11
50-Day Range
$32.11
$40.96
52-Week Range
$22.59
$49.62
Volume
13,641 shs
Average Volume
655,060 shs
Market Capitalization
$3.09 billion
P/E Ratio
57.54
Dividend Yield
N/A
Price Target
$46.43

National Vision MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
18.7% Upside
$46.43 Price Target
Short Interest
Healthy
8.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.35
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
61.36%
From $0.44 to $0.71 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

132nd out of 1,022 stocks

Ophthalmic Goods Industry

2nd out of 7 stocks

EYE stock logo

About National Vision (NASDAQ:EYE) Stock

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 1, 2022, the company operated through 1,278 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Receive EYE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.

EYE Stock News Headlines

NATIONAL VISION HOLDINGS INC
National Vision Backs FY22 Outlook As Q3 Adj. EPS Tops Estimates
National Vision (EYE) Q3 Earnings Beat Estimates
Perrigo (PRGO) Misses Q3 Earnings and Revenue Estimates
What It Means If You Have A Lazy Eye
National Vision Releases 2021 Sustainability Report
See More Headlines
Receive EYE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.

EYE Company Calendar

Last Earnings
11/10/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EYE
Fax
N/A
Employees
13,735
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$46.43
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$41.00
Forecasted Upside/Downside
+18.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$128.24 million
Pretax Margin
3.86%

Debt

Sales & Book Value

Annual Sales
$2.08 billion
Cash Flow
$2.66 per share
Book Value
$11.20 per share

Miscellaneous

Free Float
77,570,000
Market Cap
$3.09 billion
Optionable
Optionable
Beta
1.50

Key Executives

  • Mr. L. Reade FahsMr. L. Reade Fahs (Age 61)
    CEO, Pres & Director
    Comp: $2.98M
  • Mr. Patrick R. Moore (Age 58)
    Sr. VP & CFO
    Comp: $1.19M
  • Mr. Jared  BrandmanMr. Jared Brandman (Age 45)
    Sr. VP, Gen. Counsel & Sec.
    Comp: $771.63k
  • Mr. Bill Clark (Age 47)
    Sr. VP & Chief People Officer
    Comp: $726.49k
  • Ms. Melissa  RasmussenMs. Melissa Rasmussen (Age 45)
    Sr. VP & Chief Accounting Officer
  • Mr. Ravi Acharya (Age 47)
    Chief Technology Officer & Sr. VP
  • David Mann C.F.A.
    Sr. VP of Investor Relations
  • Mr. Joe VanDette
    Chief Marketing Officer
  • Mr. Alex Louw
    Sr. VP & Chief Medical Officer
  • Ms. Jacqueline Grove
    Sr. VP of Talent, Devel., Culture, Diversity, Equity & Inclusion and Philanthropy













EYE Stock - Frequently Asked Questions

Should I buy or sell National Vision stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" EYE shares.
View EYE analyst ratings
or view top-rated stocks.

What is National Vision's stock price forecast for 2023?

5 equities research analysts have issued twelve-month price objectives for National Vision's shares. Their EYE share price forecasts range from $41.00 to $60.00. On average, they expect the company's stock price to reach $46.43 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price.
View analysts price targets for EYE
or view top-rated stocks among Wall Street analysts.

How have EYE shares performed in 2022?

National Vision's stock was trading at $47.99 at the start of the year. Since then, EYE shares have decreased by 18.5% and is now trading at $39.13.
View the best growth stocks for 2022 here
.

Are investors shorting National Vision?

National Vision saw a decline in short interest in November. As of November 15th, there was short interest totaling 6,530,000 shares, a decline of 15.7% from the October 31st total of 7,750,000 shares. Based on an average daily trading volume, of 709,600 shares, the days-to-cover ratio is presently 9.2 days. Currently, 8.4% of the company's stock are sold short.
View National Vision's Short Interest
.

When is National Vision's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our EYE earnings forecast
.

How were National Vision's earnings last quarter?

National Vision Holdings, Inc. (NASDAQ:EYE) released its earnings results on Thursday, November, 10th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.08. The firm earned $499.21 million during the quarter, compared to analyst estimates of $499.85 million. National Vision had a net margin of 2.86% and a trailing twelve-month return on equity of 6.19%.

How will National Vision's stock buyback program work?

National Vision announced that its board has approved a stock buyback program on Monday, November 29th 2021, which authorizes the company to buyback $100,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 2.5% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its shares are undervalued.

What guidance has National Vision issued on next quarter's earnings?

National Vision issued an update on its FY22 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of $0.65 - $0.77 for the period, compared to the consensus EPS estimate of $0.73. The company issued revenue guidance of $1.99 - $2.02 billion, compared to the consensus revenue estimate of $2.01 billion.

What is L. Reade Fahs' approval rating as National Vision's CEO?

243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of National Vision own?
When did National Vision IPO?

(EYE) raised $300 million in an initial public offering (IPO) on Thursday, October 26th 2017. The company issued 15,800,000 shares at a price of $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

What is National Vision's stock symbol?

National Vision trades on the NASDAQ under the ticker symbol "EYE."

Who are National Vision's major shareholders?

National Vision's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.84%), Alliancebernstein L.P. (6.09%), Durable Capital Partners LP (3.90%), Macquarie Group Ltd. (3.50%), Dimensional Fund Advisors LP (2.02%) and Riverbridge Partners LLC (1.40%). Insiders that own company stock include Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Patrick R Moore and Virginia A Hepner.
View institutional ownership trends
.

How do I buy shares of National Vision?

Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Vision's stock price today?

One share of EYE stock can currently be purchased for approximately $39.13.

How much money does National Vision make?

National Vision (NASDAQ:EYE) has a market capitalization of $3.09 billion and generates $2.08 billion in revenue each year. The company earns $128.24 million in net income (profit) each year or $0.68 on an earnings per share basis.

How many employees does National Vision have?

The company employs 13,735 workers across the globe.

How can I contact National Vision?

National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The official website for the company is www.nationalvision.com. The company can be reached via phone at (770) 822-3600 or via email at investor.relations@nationalvision.com.

This page (NASDAQ:EYE) was last updated on 12/8/2022 by MarketBeat.com Staff